Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells

The immune checkpoint molecules such as PD-L1 and PD-L2 have a substantial contribution to cancer immunotherapy including breast cancer. Microarray expression profiling identified several molecular subtypes, namely luminal-type (with a good-prognosis), HER2-type (with an intermediate-prognosis), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Masanori A., Takada, Erika, Takai, Kenji, Arimitsu, Nagisa, Shimizu, Jun, Suzuki, Tomoko, Suzuki, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794171/
https://www.ncbi.nlm.nih.gov/pubmed/35085258
http://dx.doi.org/10.1371/journal.pone.0260838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794171/
https://www.ncbi.nlm.nih.gov/pubmed/35085258
http://dx.doi.org/10.1371/journal.pone.0260838

Ejemplares similares